Pfizer’s Candidate Is Technically An ‘Investigative Drug,’ Not a Vaccine Yet

The COVID-19 vaccine rollout has been making some decent progress, but technically the candidate from Pfizer can’t be labeled a “vaccine” just yet, since it has not been approved for regular use by the FDA.

Twila Brase, president and co-founder of Citizens’ Council for Health Freedom, explains why it is significant that Pfizer’s candidate is labeled as an “investigative drug.”